1. Baker DC, Hand ES, Plowman J, Rampal JB, Safavy A, Haugwitz RD, Narayanan VL (1987) Synthesis, chemical stability, and preclinical antitumor activity of pyrazine diazohydroxide, sodium salt (NSC 361456). Anti-Cancer Drug Des 2: 297–309
2. Brodfuehrer JI, Moore DJ, Melder DC, Wilke TJ, Powis G (1988)In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubation. Invest New Drugs 6:3–9
3. Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute (1984)In vivo cancer models 1976–1982. U.S. Government Printing Office, NIH Publication 84-2635
4. DeVita VT Jr, Hubbard SM, Longo DL (1987) The chemotherapy of lymphomas: looking back, moving forward — the Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res 47:5810
5. Dykes DJ, Shoemaker RH, Harrison SD Jr, Laster WR Jr, Griswold DP Jr, Mayo JG, Abbott BJ, Fine DL, Fodstad O, Boyd MR (1987) Development and therapeutic response of a spontaneous metastasis model of a human melanoma (LOX) in athymic mice. Proc Am Assoc Cancer Res 28:431